(PRESS RELEASE) VALBY, 4-Aug-2021 — /EuropaWire/ — Lundbeck (CPH: LUN), a Danish international pharmaceutical company, has announced it will partner with Rgenta Therapeutics, Cambridge, MA-based developer of oral, small-molecule RNA-targeting medicines with an initial focus on oncology, to discover small … Read the full press release
Posted in Denmark, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged disease-causing genes, Klaus Bæk Simonsen, Lundbeck, neuroscience, Rgenta Therapeutics, RNA pathways, RNA regulation, Simon Xi, small molecule RNA modulators, small molecules, Tarek Samad, treatments for brain diseases
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
